Literature DB >> 18240352

Psychological intervention reduces postembolization pain during hepatic arterial chemoembolization therapy: a complementary approach to drug analgesia.

Zi-Xuan Wang1, Si-Liang Liu, Chun-Hui Sun, Qian Wang.   

Abstract

AIM: To assess whether psychological intervention reduces postembolization pain during hepatic arterial chemoembolization therapy.
METHODS: Two hundred and sixty-two patients, who required hepatic arterial chemoembolization for hepatic malignancy and postembolization pain, were randomized into control group (n = 46, receiving medication) and intervention group (n = 216, receiving psychological intervention and medication in turn). The symptom checklist-90 (SCL-90) was used to scale the psychological symptoms of the patients before operation. Pain was scored with a 0 to 10 numeric rating scale (NRS-10) before and after analgesia as well as after psychological intervention (only in intervention group).
RESULTS: All psychological symptomatic scores measured with SCL-90 in the intervention group were higher than the normal range in Chinese (P < 0.05). The somatization, phobia and anxiety symptomatic scores were associated with pain numerical rating score before analgesia (r = 0.141, 0.157 and 0.192, respectively, P < 0.05). Patients in both groups experienced pain relief after medication, psychotherapy or psychotherapy combined with medication during the procedure (P < 0.01). Only some patients in the intervention group reported partial or entire pain relief (29.17% and 2.31%) after psychological intervention. The pain score after analgesia in the intervention group was significantly lower than that in the control group (P < 0.01).
CONCLUSION: Severe psychological distress occurs in patients with hepatic malignancy. Psychological intervention reduces pain scores significantly during hepatic arterial chemoembolization therapy and is thus, highly recommended as a complementary approach to drug analgesia.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18240352      PMCID: PMC2687062          DOI: 10.3748/wjg.14.931

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  39 in total

1.  Assessing and managing depression in the terminally ill patient. ACP-ASIM End-of-Life Care Consensus Panel. American College of Physicians - American Society of Internal Medicine.

Authors:  S D Block
Journal:  Ann Intern Med       Date:  2000-02-01       Impact factor: 25.391

2.  Racial and geographic disparities in the utilization of surgical therapy for hepatocellular carcinoma.

Authors:  Christopher J Sonnenday; Justin B Dimick; Richard D Schulick; Michael A Choti
Journal:  J Gastrointest Surg       Date:  2007-10-03       Impact factor: 3.452

3.  Transcatheter arterial chemoembolization therapy using iodized oil for patients with unresectable hepatocellular carcinoma: evaluation of three kinds of regimens and analysis of prognostic factors.

Authors:  K Ueno; N Miyazono; H Inoue; H Nishida; I Kanetsuki; M Nakajo
Journal:  Cancer       Date:  2000-04-01       Impact factor: 6.860

4.  Distraction therapy with nature sights and sounds reduces pain during flexible bronchoscopy: a complementary approach to routine analgesia.

Authors:  Gregory B Diette; Noah Lechtzin; Edward Haponik; Aline Devrotes; Haya R Rubin
Journal:  Chest       Date:  2003-03       Impact factor: 9.410

5.  Combined therapy of transcatheter arterial chemoembolisation and three-dimensional conformal radiotherapy for hepatocellular carcinoma.

Authors:  Z-H Zhou; L-M Liu; W-W Chen; Z-Q Men; J-H Lin; Z Chen; X-J Zhang; G-L Jiang
Journal:  Br J Radiol       Date:  2006-10-12       Impact factor: 3.039

6.  Arterial chemoembolization for hepatocellular carcinoma.

Authors:  Jian Fan; Gao-Jing Ten; Shi-Cheng He; Jin-He Guo; Dong-Pei Yang; Guo-Ying Wang
Journal:  World J Gastroenterol       Date:  1998-02       Impact factor: 5.742

Review 7.  Psychological approaches to understanding and treating disease-related pain.

Authors:  Francis J Keefe; Amy P Abernethy; Lisa C Campbell
Journal:  Annu Rev Psychol       Date:  2005       Impact factor: 24.137

8.  Psychiatric morbidity in terminally ill cancer patients. A prospective study.

Authors:  H Minagawa; Y Uchitomi; S Yamawaki; K Ishitani
Journal:  Cancer       Date:  1996-09-01       Impact factor: 6.860

9.  Radiofrequency ablation in the management of liver metastases from breast cancer.

Authors:  C T Sofocleous; R G Nascimento; M Gonen; M Theodoulou; A M Covey; L A Brody; S M Solomon; R Thornton; Y Fong; G I Getrajdman; K T Brown
Journal:  AJR Am J Roentgenol       Date:  2007-10       Impact factor: 3.959

10.  Survival rates according to the Cancer of the Liver Italian Program scores of 345 hepatocellular carcinoma patients after multimodality treatments during a 10-year period in a retrospective study.

Authors:  Kentaro Yamagiwa; Katsuya Shiraki; Koichiro Yamakado; Shugo Mizuno; Tomohide Hori; Shinichiro Yagi; Takashi Hamada; Taku Iida; Ikuo Nakamura; Koji Fujii; Masanobu Usui; Shuji Isaji; Keiichi Ito; Shinsei Tagawa; Kan Takeda; Hajime Yokoi; Takashi Noguchi
Journal:  J Gastroenterol Hepatol       Date:  2007-12-13       Impact factor: 4.029

View more
  3 in total

1.  Health education helps to relieve postembolization pain during hepatic arterial chemoembolization therapy.

Authors:  Zi Xuan Wang; Lin Li; Feng Ying Tao
Journal:  J Pain Res       Date:  2018-09-28       Impact factor: 3.133

2.  Determination of Risk Factors for Pain After Transarterial Chemoembolization with Drug-Eluting Beads for Hepatocellular Carcinoma.

Authors:  Tian-Cheng Wang; Zi-Shu Zhang; Yu-Dong Xiao
Journal:  J Pain Res       Date:  2020-03-27       Impact factor: 3.133

3.  Intraarterial Lidocaine Administration for Pain Control by Water-in-Oil Technique in Transarterial Chemoembolization: in vivo and Randomized Clinical Trial.

Authors:  Li-Zhou Wang; Xiao-Xia Hu; Xiang-Chun Shen; Tian-Cheng Wang; Shi Zhou
Journal:  J Hepatocell Carcinoma       Date:  2021-10-05
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.